Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Diseases of the esophagus

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/dote.12315PMID 25604614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer.

  2015cited by this paper
• Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy.

  2013cited by this paper
• Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer

  2013cited by this paper
• Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.

  2013cited by this paper
• Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.

  2013cited by this paper
• Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology

  2013cited by this paper
• Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?

  2012cited by this paper
• Preoperative chemoradiotherapy for esophageal or junctional cancer.

  2012cited by this paper
• Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.

  2012cited by this paper
• Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use?

  2012cited by this paper
• Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival.

  2012cited by this paper
• Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer.

  2011cited by this paper
• Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis

  2011cited by this paper
• 18F-FDG PET–Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial

  2011cited by this paper
• Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

  2011cited by this paper
• Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer

  2011cited by this paper
• Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

  2011cited by this paper
• Apparent Diffusion Coefficient Values Measured by Diffusion-Weighted Imaging Predict Chemoradiotherapeutic Effect for Advanced Esophageal Cancer

  2011cited by this paper
• Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02).

  2010cited by this paper
• Early Repeated 18F-FDG PET Scans During Neoadjuvant Chemoradiation Fail to Predict Histopathologic Response or Survival Benefit in Adenocarcinoma of the Esophagus

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• 18F-Fluorodeoxiglucose Positron Emission Tomography for the Evaluation of Neoadjuvant Therapy Response in Esophageal Cancer: Systematic Review of the Literature

  2009cited by this paper
• Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.

  2009cited by this paper
• Imaging of tumor angiogenesis: functional or targeted?

  2009cited by this paper
• Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy.

  2009cited by this paper
• Controversies in the use of endoscopic ultrasound in esophageal cancer staging

  2009cited by this paper
• Molecular Imaging of Hypoxia

  2008cited by this paper
• Are patients with esophageal cancer who become PET negative after neoadjuvant chemoradiation free of cancer?

  2008cited by this paper
• A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy.

  2008cited by this paper
• Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow.

  2008cited by this paper
• Assessment of tumor microcirculation with dynamic contrast‐enhanced MRI in patients with esophageal cancer: Initial experience

  2008cited by this paper
• Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer

  2008cited by this paper
• Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.

  2008cited by this paper
• Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction

  2007cited by this paper
• Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.

  2007cited by this paper
• Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.

  2007cited by this paper
• Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma.

  2007cited by this paper
• Detection of interval distant metastases

  2007cited by this paper
• Diffusion-weighted MRI in the body: applications and challenges in oncology.

  2007cited by this paper
• PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

  2007cited by this paper
• Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy.

  2006cited by this paper
• Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers.

  2006cited by this paper
• 18FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response

  2006cited by this paper
• Imaging oxygenation of human tumours

  2006cited by this paper
• Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer

  2006cited by this paper
• Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

  2006cited by this paper
• Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review.

  2005cited by this paper
• Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer.

  2005cited by this paper
• The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.

  2005cited by this paper
• FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer.

  2005cited by this paper
• Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.

  2004cited by this paper
• Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.

  2004cited by this paper
• Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods.

  2003cited by this paper
• Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging

  2003cited by this paper
• Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial.

  2003cited by this paper
• Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma.

  2002cited by this paper
• Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.

  2002cited by this paper
• Evaluation of response to neoadjuvant therapy by quantitative 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography in patients with esophageal cancer.

  2002cited by this paper
• Clinical impact of endoscopic ultrasound-guided fine needle aspiration of celiac axis lymph nodes (M1a disease) in esophageal cancer.

  2002cited by this paper
• Effects of Radiation on Tumor Intravascular Oxygenation, Vascular Configuration, Development of Hypoxia, and Clonogenic Survival

  2001cited by this paper
• Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.

  2001cited by this paper
• Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy

  1999cited by this paper
• Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy.

  1999cited by this paper
• Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT.

  1999cited by this paper
• Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols

  1999cited by this paper
• Using endosonography to assess the effects of neoadjuvant therapy in patients with advanced esophageal cancer.

  1997cited by this paper
• Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation.

  1996cited by this paper

• CT-Derived Quantitative Image Features Predict Neoadjuvant Treatment Response in Adenocarcinoma of the Gastroesophageal Junction with High Accuracy

  2025cites this paper
• MR outperformed CT in evaluating RECIST response to neoadjuvant therapy in locally advanced esophageal squamous cell carcinoma.

  2025cites this paper
• Investigation of the diagnostic and prognostic impact of posttreatment fluorine-18 fluorodeoxyglucose PET/computed tomography on M0 esophageal cancer.

  2025cites this paper
• Comparative evaluation of imaging methods for prognosis assessment in esophageal squamous cell carcinoma: focus on diffusion-weighted magnetic resonance imaging, computed tomography and esophagography

  2024cites this paper
• Baseline and interim [18F]FDG-PET/MRI to assess treatment response and survival in patients with M0 esophageal squamous cell carcinoma treated by curative-intent therapy

  2023cites this paper
• Does radiomics play a role in the diagnosis, staging and re-staging of gastroesophageal junction adenocarcinoma?

  2022cites this paper
• The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma

  2021cites this paper
• Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma?

  2021cites this paper
• Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagus.

  2020cites this paper
• Added value of MRI to endoscopic and endosonographic response assessment after neoadjuvant chemoradiotherapy in oesophageal cancer

  2020cites this paper
• Preoperative prediction of pathologic response to neoadjuvant chemoradiotherapy in patients with esophageal cancer using 18F-FDG PET/CT and DW-MRI: a prospective multicenter study.

  2020cites this paper
• New frontiers in esophageal radiology

  2020cites this paper
• Contribution of magnetic resonance imaging to the management of esophageal diseases: A systematic review.

  2019cites this paper
• Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus

  2019cites this paper
• Diffusion-weighted MRI with ADC mapping for response prediction and assessment of oesophageal cancer: A systematic review.

  2019cites this paper
• Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer

  2019cites this paper
• Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study

  2018cites this paper
• Novel imaging techniques in staging oesophageal cancer.

  2018cites this paper